McGill University at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

McGill University brings 3 presentations to ISLB 2026 in Madrid. Its work spans tumour DNA monitoring and protein profiling in blood across breast cancer, colorectal cancer and leiomyosarcoma. One study compares droplet digital PCR with next-generation sequencing for detecting ESR1 mutations in metastatic breast cancer.

OrganizationISLB 2026 Attendance
McGill University
Montreal, Canada
mcgill.ca
Universities & research institutes
Public research university in Montreal, Quebec, with a faculty of medicine and affiliated teaching hospitals.
Poster
Poster
Part of Poster sessions
ESR1 Mutations in HR+/HER2-metastatic Breast Cancer: a Comparative Analysis Between ddPCR and NGS
Clinical use · ctDNA & MRD
Collaborators: McGill University Health Centre
Poster

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from McGill University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction